RPL34P14: A Promising Drug Target / Biomarker (G100129934)

Target Name: RPL34P14

NCBI ID: G100129934

RPL34P14

Other Name(s): RPL34_9_693 | ribosomal protein L34 pseudogene 14 | Ribosomal protein L34 pseudogene 14

RPL34P14: A Promising Drug Target / Biomarker

RPL34P14 is a gene that encodes a protein known as P14, which is a key regulator of the microtubule network. Microtubules are a protein structure that organizes and transports organelles in cells, and they play a crucial role in cell division, intracellular transport, and other cellular processes. The regulation of microtubule dynamics is a critical aspect of cell biology, and the misregulation of microtubules has been implicated in the development and progression of many diseases, including cancer. Therefore, the study of P14 and its function as a drug target or biomarker is of great interest.

P14 Regulates Microtubule Dynamics

P14 is a 22-kDa protein that consists of a 21 kDa alpha-helices and a 10 kDa carboxy-terminal tail. It plays a crucial role in regulating microtubule dynamics by interacting with the microtubules and altering their stability. P14 interacts with the microtubules through its N-terminus, which contains a unique domain that is involved in the regulation of microtubule stability.

Stability of Microtubules

Microtubules are dynamic structures that are constantly in a state of transition, as they can be resynthesized and disassembled in a process called dynamicity. The stability of microtubules is regulated by several factors, including the size and composition of the microtubules, the dynamics of the tubulin protein, and the regulation of the microtubule dynamics by factors such as kinesins and microtubule-associated proteins (MAPs).

P14 Regulates Microtubule Stability

P14 is known to regulate microtubule stability by interacting with the microtubules and altering their stability. P14 has been shown to interact with the alpha-helices of microtubules and to regulate the stability of these interactions. Specifically, P14 has been shown to prevent the inversion of the microtubule alpha-helices, which is a critical event that allows for the stability of the microtubules.

P14 Interacts with Microtubules

P14 has been shown to interact with the microtubules through its N-terminus, which contains a unique domain that is involved in the regulation of microtubule stability. The N-terminus of P14 contains a domain that is similar to the N-terminus of tubulin protein, and this domain is involved in the regulation of microtubule stability.

Expression and Localization

P14 is highly expressed in many tissues and cells, including muscle, brain, and cancer cells. It is also shown to be expressed in various tissues and cells associated with the development and progression of diseases, including cancer. P14 is predominantly localized to the cytoplasm of the cells, and it is also shown to be present in the endoplasmic reticulum (ER).

Drug Targeting

P14 is a potential drug target due to its unique function as a regulator of microtubule dynamics. Activation of P14 has been shown to inhibit the formation of new microtubules, leading to a reduction in cell proliferation. Therefore, P14 is a potential target for cancer therapies that focus on inhibiting microtubule dynamics.

Conclusion

In conclusion, P14 is a gene that encodes a protein that plays a crucial role in regulating microtubule dynamics. Its regulation of microtubule stability is a critical aspect of cell biology, and the misregulation of microtubules has been implicated in the development and progression of many diseases. Therefore, the study of P14 and its function as a drug target or biomarker is of great interest. Further research is needed to fully understand the role of P14 in

Protein Name: Ribosomal Protein L34 Pseudogene 14

The "RPL34P14 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RPL34P14 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets